Nabil Azar, MD
Hospitalist · Gulfport, MSNPI 1033159140
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $335 and has fallen 90.8% since, to $31 in 2025.
Across 54 payments — averaging $20.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$212
- UCB, Inc.$189
- Johnson & Johnson$137
- Novo Nordisk$112
- Jazz Pharmaceuticals Inc.$104
- Novartis$99
- plus $235 from 9 others
What the payments were for
- Food & beverage$1,087100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 15 | $212 |
| UCB, Inc. | 6 | $189 |
| Johnson & Johnson | 7 | $137 |
| Novo Nordisk | 7 | $112 |
| Jazz Pharmaceuticals Inc. | 1 | $104 |
| Novartis | 7 | $99 |
| Lexicon Pharmaceuticals, Inc. | 2 | $61 |
| AstraZeneca | 2 | $37 |
| AbbVie | 1 | $28 |
| Amgen | 1 | $27 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Boehringer Ingelheim | 1 | $16 |
| Boston Scientific | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Mallinckrodt Enterprises LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Epidiolex$104
How this compares
$1,087 in reported general payments places this provider in the 65th percentile of 102 hospitalist providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 14 | $77 |
| Prednisone | 14 | $27 |
| Amlodipine Besylate | 12 | $17 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Gulfport
- Summer AllenGulfport$53K
- Nathan BolesGulfport$3K
- Dasha CowartGulfport$2K
- Melissa Moon MuirheadGulfport$2K
- Hari RaoGulfport$2K
- John GradyGulfport$2K
- Hamza LodhiSouthaven$164K
- Stephen FarrowBiloxi$7K
- Kenneth BallJackson$3K
- Frederick AsherJackson$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.